Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

NCT03098589 · clinicaltrials.gov ↗
COMPLETED
Status
1149
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene